Deroxi Liposomal 2 mg/ml Concentrate for solution for infusion 10ml Vial
Product Description
Deroxi Liposomal 2 mg/ml Concentrate for solution for infusion is an advanced pharmaceutical formulation designed for intravenous administration.
This product utilizes liposomal technology, which encapsulates the active ingredient, Deroxi, within microscopic lipid vesicles.
This innovative delivery system aims to improve the drug's therapeutic profile by enhancing its stability, prolonging its circulation time in the body, and potentially reducing adverse effects compared to conventional formulations.
Each 10ml vial contains a potent 2 mg/ml concentration, making it suitable for dilution prior to infusion.
This concentrate is primarily intended for use in specialized medical settings under the strict supervision of healthcare professionals.
Benefits of Use
- Enhanced Drug Delivery: Liposomal encapsulation helps in more efficient delivery of the active ingredient to target tissues.
- Reduced Toxicity: May lower the risk of certain systemic side effects often associated with conventional drug forms.
- Improved Pharmacokinetics: Contributes to a more stable and prolonged presence of the drug in the bloodstream.
- Precise Dosing: The concentrated formulation allows for accurate and flexible dosing tailored to patient needs.
How to Use
- Deroxi Liposomal Concentrate must only be administered by a qualified healthcare professional.
- Prior to administration, the concentrate must be diluted according to specific medical guidelines and the prescribing physician's instructions.
- Administer as a slow intravenous infusion over the recommended duration to ensure optimal patient tolerance and efficacy.
- Monitor the patient closely during and after infusion for any signs of adverse reactions.
- Ensure proper aseptic technique is maintained throughout the preparation and administration process.
Caution & Warnings
- For Intravenous Use Only: Do not administer by any other route.
- Dilution Required: Always dilute the concentrate before infusion as directed.
- Hypersensitivity: Patients with known hypersensitivity to the active ingredient or any excipients should not use this product.
- Monitor for Infusion Reactions: Patients should be carefully monitored for infusion-related reactions, especially during the initial stages of administration.
- Pregnancy and Lactation: Use with caution in pregnant or breastfeeding women only if clearly indicated and potential benefits outweigh risks. Consult a physician.
- Drug Interactions: Inform your doctor or pharmacist about all other medications you are taking, including over-the-counter drugs and herbal supplements.
- Storage: Store as per specific instructions provided on the packaging; typically, below 25°C and protected from light.
Ingredients
- Active Ingredient: Deroxi (2 mg/ml)
- Lipid Excipients: (Specific lipids used in liposomal formulation, e.g., phospholipids, cholesterol – will state generally as 'Lipid Excipients')
- Other Excipients: Water for injection, pH adjusters, and other pharmaceutical aids necessary for solution stability.
Product Details
- Form: Concentrate for solution for infusion
- Strength: 2 mg/ml
- Package Size: 10ml Vial
- Administration Route: Intravenous
| Gtin | 2301244786 |
|---|---|
| Recommended Sale Price | 1493.05 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | DOXORUBICIN HYDROCHLORIDE |
| SFDA Reg. No | 2301244786 |
| IBC | 2301244786 |
| Drug Type | Prescription |
| Strength | 2 mg/ml |
| Strength Unit | mg/ml |
| Form | Concentrate for solution for infusion |
| Admin Route | Intravenous |
| Size | 10 |
| Size Unit | ml |
| Package Types | Vial |
| Package Size | 10ml Vial |
| Storage conditions | Store below 25°C and protected from light. |
| Refrigerator Storage | No |

